MedDataX Logo

Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing

NCT07022561 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2025-06-15

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the Social Prescription (SP) intervention helps improve mental health and wellbeing in youth. It will also assess the feasibility and acceptability of implementing SP in a community setting. The main questions it aims to answer are:

* Is the SP intervention feasible and acceptable for youth, caregivers, and staff?
* Does the SP intervention improve mental health outcomes, reduce stress, and increase wellbeing and social connectedness in youth?

Researchers will compare the Social Prescription (SP) intervention to an education control group to evaluate its effectiveness in improving youth mental health and wellbeing.

Participants will:

* Be randomized to receive either the SP intervention or be placed in an education control group
* Complete wellbeing and mental health questionnaires at the beginning of the study and again after 12 weeks
* Participate in qualitative interviews to share their experiences after participating in SP

Conditions

  • Youth Mental Health and Wellbeing
  • Feasibility and Acceptability of the Social Prescribing Program

Interventions

BEHAVIORAL

Social Prescribing

A social prescribing intervention is a non-clinical approach to improving health and wellbeing by connecting individuals to community-based services and activities that address social, emotional, and practical needs. These may include arts programs, physical activity, peer support, volunteering, or nature-based activities. Facilitated by a link worker or navigator, social prescribing is tailored to the individual and aims to enhance mental health, reduce isolation, and support overall wellness beyond traditional medical care.

Sponsors & Collaborators

  • Children's Hospital of Eastern Ontario Research Institute

    collaborator OTHER

  • University of Ottawa

    lead OTHER

Principal Investigators

  • Nicole Racine, PhD · University of Ottawa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2027-07-30
Completion
2027-09-01

Countries

  • Canada

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022561 on ClinicalTrials.gov